Breaking News
Top News
-
The Procter & Gamble Company (PG): Research Push Translating Into Market Share Gains
-
The Coca-Cola Company (KO): Investors Hedge Against Economic Volatility
-
UnitedHealth Group (UNH): Vertical Integration Resilience Woos Safe Investors
-
Micron Technology (MU): The Next Trillion-Dollar Giant Hiding in Your Watchlist
-
Nike to cut 1,400 jobs amid sales slowdown
-
Hedge Fund Launched by Instacart Co-Founder Has AI Call Shots
-
Stocks Can Handle ‘Stalemate Situation’ in Iran, Yardeni Says
-
Earnings Are Surprisingly Strong, Says Morgan Stanley’s Wilson
-
Why Our Labor Market Is Forever Changed
-
Inflation Fears Drive Consumer Sentiment to Record Low
-
DOJ Expected to Drop Powell Investigation: ABC
-
Finma Says Immediate Mythos Access Would Pose Systemic Bank Risk
-
Meet the Comedian Poised to Oversee Right-Wing Infowars
-
War Buoys Arms Makers’ Sales, but Not Their Stocks
-
Western Union Profit Falls as Immigration Policy Hurts Remittances
-
Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models
-
Vertex Pharmaceuticals Incorporated (VRTX) PT Nudged Higher as RBC Updates Biotech Sector Outlook
-
Caris Life Sciences, Inc. (CAI) Coverage Begins at Neutral as Piper Cites Need for Growth Acceleration
-
IDEAYA Biosciences, Inc. (IDYA) PT Increased as Wedbush Highlights Positive OptimUM-02 Trial Readout
-
FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)’s KT-621 for Eosinophilic Asthma
2026-02-05



































